Erector Spinae Plane Block Catheters and Intrathecal Morphine for Hepatic Resection
Trial statusRecruiting
Trial phasePhase 4
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity of California, San Diego
About this trial
To determine whether the addition of erector spinae plane (ESP) catheters to existing multimodal analgesic regimen with intrathecal morphine provides superior postoperative analgesia in patients undergoing hepatic resection compared with patients not receiving ESP catheters.
Eligibility criteria
Qualifiers
undergoing hepatic resection
Admitting service requests APS consult
>18 years old and able to provide consent
Disqualifiers
pregnancy
incarceration
inability to communicate with the investigators and hospital staff
severe hepatic disease
Trial design
Treatments tested in this trial
- 0.2% ropivacaine local anesthetic continuous erector spinae plane block
- 0.2% ropivacaine local anesthetic superficially taped continuous erector spinae plane block
- Spinal Morphine
Treatment groups
70 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov